Plenary III, Abstract 1726: Mayo research shows arthritis from cancer immunotherapy is NOT the same as rheumatoid arthritis!
Key finding: It’s driven by overactive T cells, not autoantibodies. This means different treatments may be needed. #ACR25
@mbinvignat.bsky.social
MD. PhD in Systems Immunology Sorbonne University Rheumatology Fellow AP-HP
Plenary III, Abstract 1726: Mayo research shows arthritis from cancer immunotherapy is NOT the same as rheumatoid arthritis!
Key finding: It’s driven by overactive T cells, not autoantibodies. This means different treatments may be needed. #ACR25
The T cells in these patients showed increased metabolic activity. Elevated levels of inflammatory molecules (IL-6, IL-12, and type I interferon) may be driving the aggressive T cell behavior. #ACR25
28.10.2025 14:14 — 👍 2 🔁 2 💬 1 📌 0Atul Butte, MD, PhD, helped define the field of translational bioinformatics and inspired countless colleagues and trainees.
He will be remembered for his brilliant mind, infectious optimism, generous mentorship.
👩🔬I'm thrilled to share my 1st paper, published in @oacjournal.bsky.social
🔍In this sytematic review on HLA and TCR repertoire in osteoarthritis we found that high-througput analysis are needed in the field!
👏Big thanks to @mbinvignat.bsky.social @jeremiesellam.bsky.social @enkrnita.bsky.social
Fresh from the oven 🧨💥
We show that CD4 T cells, especially Tregs, control host-microbiota symbiosis and intestinal barrier integrity to prevent inflammaging, tissue senescence and aging-related multimorbidity
🔥 👵🏻
www.science.org/doi/10.1126/...
Congrats to @mariamarcosalvador.bsky.social on her first publication, just out in @oacjournal.bsky.social !
A systematic literature review on TCR and HLA in osteoarthritis:
🔗 www.oarsijournal.com/article/S106...
@enkrnita.bsky.social @jeremiesellam.bsky.social @sorbonne-universite.fr
The UCSF community mourns the passing of Atul Butte, MD, PhD, a bold thinker, inspiring mentor and founding director of the Bakar Computational Health Sciences Institute.
tiny.ucsf.edu/tGz3QY
Review @natrevrheum.nature.com @deepakarao.bsky.social
Immune-cell profiling to guide stratification and treatment of patients with rheumatic diseases
www.nature.com/articles/s41...
Recently in #Science #Immunology: Van der Veeken & al @ IMP @viennabiocenter.bsky.social generated 🐁 w auxin-inducible degradable #Foxp3! Tissue #Tregs minimally unaffected @ homeostasis but highly dependent on continuous Foxp3 activity in models of #autoimmunity, #viral #infection, & #cancer !
20.06.2025 06:51 — 👍 19 🔁 3 💬 0 📌 0🚨 NEW 🚨
🤩 This month's Editors Choice (Clinical) is about intestinal health and hand #osteoarthritis
Read more from @mbinvignat.bsky.social @jeremiesellam.bsky.social - www.oarsijournal.com/article/S106...
Check out our new editorial on molecular endotypes and theratypes in osteoarthritis with @jeremiesellam.bsky.social, just out in Annals of the Rheumatic Diseases
ard.eular.org/article/S000...
@crsa-paris.bsky.social @sorbonne-universite.fr
We’re proud to celebrate @atulbutte.bsky.social on his election to the American Academy of Arts and Sciences, one of the nation’s oldest honor societies. A leader in biomedical data science, his work is reshaping how we diagnose and treat disease. tiny.ucsf.edu/CUz7gN
01.05.2025 18:20 — 👍 10 🔁 3 💬 0 📌 0Happy to share our new article on Intestinal Permeability serum biomarkers in Erosive hand OA with @jeremiesellam.bsky.social @larhumato.bsky.social @enkrnita.bsky.social and team
Read the paper here: www.oarsijournal.com/article/S106...
@crsa-paris.bsky.social @oacjournal.bsky.social